James R Neal insider trades: Processa Pharmaceuticals (PCSA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | PCSA | ↑ Buy | 789 | $2.54 | $2K | Direct | Apr 2, 2026 (2d) |
| Jul 15, 2022 | XOMA | ↓ Sell | 25,000 | $29.84 | $746K | Direct | Jul 18, 2022 (3d) |
| Mar 23, 2022 | XOMA | ↓ Sell | 53,450 | $29.07 | $1.6M | Direct | Mar 23, 2022 (0d) |
| Jun 25, 2021 | XOMA | ↓ Sell | 9,027 | $33.62 | $303K | Direct | Jun 29, 2021 (4d) |
| Dec 15, 2020 | XOMA | ↓ Sell | 26,000 | $41.35 | $1.1M | Direct | Dec 17, 2020 (2d) |
| Nov 23, 2020 | XOMA | ↓ Sell | 20,000 | $32.81 | $656K | Direct | Nov 24, 2020 (1d) |
| Nov 5, 2020 | XOMA | ↓ Sell | 10,000 | $26.02 | $260K | Direct | Nov 6, 2020 (1d) |
| Mar 23, 2020 | XOMA | ↑ Buy | 1,000 | $14.50 | $15K | Direct | Mar 24, 2020 (1d) |
| Mar 20, 2020 | XOMA | ↑ Buy | 1,000 | $16.41 | $16K | Direct | Mar 23, 2020 (3d) |
| Nov 6, 2019 | XOMA | ↓ Sell | 4,348 | $22.00 | $96K | Direct | Nov 8, 2019 (2d) |
| Sep 20, 2019 | XOMA | ↓ Sell | 15,652 | $21.02 | $329K | Direct | Sep 20, 2019 (0d) |
| Nov 13, 2018 | XOMA | ↑ Buy | 4,000 | $13.26 | $53K | Direct | Nov 15, 2018 (2d) |
| Apr 27, 2018 | XOMA | ↓ Sell | 24,000 | $24.51 | $588K | Direct | Apr 27, 2018 (0d) |
| Nov 15, 2017 | XOMA | ↓ Sell | 46,296 | $28.24 | $1.3M | Direct | Nov 15, 2017 (0d) |
| Mar 21, 2017 | XOMA | ↓ Sell | 5,105 | $5.40 | $28K | Direct | Mar 23, 2017 (2d) |
| Feb 1, 2017 | XOMA | ↓ Sell | 195 | $4.52 | $881 | Direct | Feb 1, 2017 (0d) |
| Jan 9, 2017 | XOMA | ↓ Sell | 125 | $5.15 | $644 | Direct | Jan 10, 2017 (1d) |
| Nov 1, 2016 | XOMA | ↓ Sell | 150 | $5.25 | $788 | Direct | Nov 3, 2016 (2d) |
| Oct 7, 2016 | XOMA | ↓ Sell10b5-1 | 2,500 | $0.45 | $1K | Direct | Oct 11, 2016 (4d) |
| Mar 22, 2016 | XOMA | ↓ Sell | 19,813 | $0.78 | $16K | Direct | Mar 22, 2016 (0d) |
| Nov 26, 2014 | XOMA | ↓ Sell | 1,678 | $5.67 | $10K | Direct | Dec 1, 2014 (5d) |
| Nov 24, 2014 | XOMA | ↓ Sell | 1,032 | $5.03 | $5K | Direct | Nov 24, 2014 (0d) |
| Nov 13, 2014 | XOMA | ↓ Sell | 4,387 | $3.89 | $17K | Direct | Nov 17, 2014 (4d) |
| Aug 15, 2014 | XOMA | ↓ Sell | 6,584 | $4.61 | $30K | Direct | Aug 18, 2014 (3d) |
| Mar 18, 2014 | XOMA | ↓ Sell | 2,671 | $6.32 | $17K | Direct | Mar 20, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCSA insiders
Open-market trades in the last 12 months
About James R Neal's insider trades
James R Neal is an insider at Processa Pharmaceuticals (PCSA). Since Mar 18, 2014, James has reported 4 open-market purchases worth $86K and 21 sales worth $7.0M on SEC Form 4. In the last 12 months: 1 buy ($2K).
1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (27 filings), option exercises (14 filings), shares returned to the company (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.